• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.53% Nasdaq Down 1.33%

    More On ACU.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Acuvax Limited (ACU.AX)

    -ASX
    0.25 0.00(0.00%) Mar 11
    Add to Portfolio
    Prev Close:0.25
    Open:0.02
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.02 - 0.25
    52wk Range:0.02 - 2.50
    Volume:1,064,479
    Avg Vol (3m):38,623
    Market Cap:3.42M
    P/E (ttm):N/A
    EPS (ttm):-0.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in AUD.

    Headlines

    • No Headlines available for ACU.AX at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):716.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acuvax Limited primarily researches and develops cancer therapies in Australia. It is also involved in the development of viruses and vaccines. The company is based in West Perth, Australia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback